DarioHealth Corp EBITDA vs. Return On Equity
| DRIO Stock | USD 1.50 0.05 3.45% |
EBITDA | First Reported 2010-12-31 | Previous Quarter -50.8 M | Current Value -48.3 M | Quarterly Volatility 22.2 M |
For DarioHealth Corp profitability analysis, we use financial ratios and fundamental drivers that measure the ability of DarioHealth Corp to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well DarioHealth Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between DarioHealth Corp's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of DarioHealth Corp over time as well as its relative position and ranking within its peers.
DarioHealth |
Is DarioHealth Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DarioHealth Corp. If investors know DarioHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DarioHealth Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.93) | Revenue Per Share 0.717 | Quarterly Revenue Growth (0.47) | Return On Assets (0.33) | Return On Equity (0.86) |
The market value of DarioHealth Corp is measured differently than its book value, which is the value of DarioHealth that is recorded on the company's balance sheet. Investors also form their own opinion of DarioHealth Corp's value that differs from its market value or its book value, called intrinsic value, which is DarioHealth Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DarioHealth Corp's market value can be influenced by many factors that don't directly affect DarioHealth Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DarioHealth Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if DarioHealth Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DarioHealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
DarioHealth Corp Return On Equity vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining DarioHealth Corp's current stock value. Our valuation model uses many indicators to compare DarioHealth Corp value to that of its competitors to determine the firm's financial worth. DarioHealth Corp is rated below average in ebitda category among related companies. It is rated below average in return on equity category among related companies . DarioHealth Corp reported last year EBITDA of (50.84 Million). Comparative valuation analysis is a catch-all model that can be used if you cannot value DarioHealth Corp by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for DarioHealth Corp's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the DarioHealth Corp's earnings, one of the primary drivers of an investment's value.DarioHealth Return On Equity vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
DarioHealth Corp |
| = | (50.84 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
DarioHealth Corp |
| = | -0.86 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
DarioHealth Return On Equity Comparison
DarioHealth Corp is currently under evaluation in return on equity category among related companies.
DarioHealth Corp Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in DarioHealth Corp, profitability is also one of the essential criteria for including it into their portfolios because, without profit, DarioHealth Corp will eventually generate negative long term returns. The profitability progress is the general direction of DarioHealth Corp's change in net profit over the period of time. It can combine multiple indicators of DarioHealth Corp, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 0.00 | 0.00 | |
| Operating Income | -56.1 M | -53.3 M | |
| Income Before Tax | -59.4 M | -56.4 M | |
| Total Other Income Expense Net | -3.3 M | -3.1 M | |
| Net Loss | -54.9 M | -52.1 M | |
| Income Tax Expense | 64 K | 60.8 K | |
| Net Loss | -57.8 M | -54.9 M | |
| Non Operating Income Net Other | -4.8 M | -4.6 M | |
| Net Loss | -56 M | -53.2 M | |
| Interest Income | 1.7 M | 1.8 M | |
| Net Interest Income | -820 K | -779 K | |
| Change To Netincome | 19.5 M | 20.5 M | |
| Net Loss | (1.93) | (2.03) | |
| Income Quality | 0.55 | 0.54 | |
| Net Income Per E B T | 0.92 | 1.08 |
DarioHealth Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on DarioHealth Corp. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of DarioHealth Corp position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the DarioHealth Corp's important profitability drivers and their relationship over time.
Use DarioHealth Corp in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DarioHealth Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DarioHealth Corp will appreciate offsetting losses from the drop in the long position's value.DarioHealth Corp Pair Trading
DarioHealth Corp Pair Trading Analysis
The ability to find closely correlated positions to DarioHealth Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DarioHealth Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DarioHealth Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DarioHealth Corp to buy it.
The correlation of DarioHealth Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DarioHealth Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DarioHealth Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DarioHealth Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your DarioHealth Corp position
In addition to having DarioHealth Corp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Non-Metallic and Industrial Metal Mining Thematic Idea Now
Non-Metallic and Industrial Metal Mining
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Non-Metallic and Industrial Metal Mining theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Non-Metallic and Industrial Metal Mining Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Investing Opportunities. To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for DarioHealth Stock analysis
When running DarioHealth Corp's price analysis, check to measure DarioHealth Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DarioHealth Corp is operating at the current time. Most of DarioHealth Corp's value examination focuses on studying past and present price action to predict the probability of DarioHealth Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DarioHealth Corp's price. Additionally, you may evaluate how the addition of DarioHealth Corp to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets |
To fully project DarioHealth Corp's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of DarioHealth Corp at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include DarioHealth Corp's income statement, its balance sheet, and the statement of cash flows.